Molecule intelOpportunity: Moderate0

Semaglutide

9 brands · 7 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
40
Market saturation
18
Price room
100
Regulatory risk
50
9
brands
7
companies
Rs 3,475
median price
22
price points
30.67x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 22%

Price room

Across observed sources and strengths
CheapestRs 950
MedianRs 3,475
Most expensiveRs 29,135.68
Spread30.67×
Sources: DVAGO

max/min price ratio 30.67x across 22 trusted points (Rs 950.0-29135.68). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Semaglutide — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2023-07-14
Rapid Alert: Drug Product; Suspected increase in the availability of falsified versions of

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(82) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

7 canonical companies and 9 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 30.67x across 22 trusted points (Rs 950.0-29135.68). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2023-07-14 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.